Cited by 475Coronary Interventions and DiagnosticsCardiac Imaging and DiagnosticsCerebrovascular and Carotid Artery Diseases

The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.

Intravascular Ultrasound-Derived Measures of Coronary Atherosclerotic Plaque Burden and Clinical Outcome

Open access

Nicholls, Stephen J., Hsu, Amy, Wolski, Kathy, Hu, Bo, Bayturan, Ozgur, Lavoie, Andrea, Uno, Kiyoko, Tuzcu, E. Murat, Nissen, Steven E.·2010·Journal of the American College of Cardiology

DOI 10.1016/j.jacc.2010.02.026

Open this paper in CoChat — free account Open PDF

Abstract

Objectives The aim of this study was to investigate the relationship between intravascular ultrasound (IVUS)-derived measures of atherosclerosis and cardiovascular outcomes.Background IVUS has been used in clinical trials to evaluate the effect of medical therapies on coronary atheroma progression.Methods Coronary plaque progression was evaluated in 4,137 patients in 6 clinical trials that used serial IVUS. The relationship between baseline and change in percent atheroma volume (PAV) and total atheroma volume with incident major adverse cardiovascular events (MACE) was investigated.Results PAV increased by 0.3% (p < 0.001), and 19.9% of subjects experienced MACE (0.9% death, 1.8% myocardial infarction, 18.9% coronary revascularization). Greater baseline PAVs were observed in patients who experienced myocardial infarctions (42.2 +/- 9.6% vs. 38.6 +/- 9.1%, p = 0.001), coronary revascularization (41.2 +/- 9.3% vs. 38.1 +/- 9.0%, p < 0.001), or MACE (41.3 +/- 9.2% vs. 38.0 +/- 9.0%, p < 0.001). Each standard deviation increase in PAV was associated with a 1.32-fold (95% confidence interval: 1.22 to 1.42; p < 0.001) greater likelihood of experiencing a MACE. During follow-up (21.1 +/- 3.7 months), greater increases in PAV, but not total atheroma volume, were observed in subjects who experienced MACE compared with those who did not (0.95 +/- 0.19% vs. 0.46 +/- 0.16%, p < 0.001). Each standard deviation increase in PAV was associated with a 1.20-fold (95% confidence interval: 1.10 to 1.31; p < 0.001) greater risk for MACE. Multivariate analysis revealed that factors associated with MACE included baseline PAV (p < 0.0001), change in PAV (p = 0.002), smoking (p = 0.0002) and hypertension (p = 0.01).Conclusions A direct relationship was observed between the burden of coronary atherosclerosis, its progression, and adverse cardiovascular events. The relationship between disease progression and outcomes largely reflected the need for coronary revascularization. These data support the use of atherosclerosis imaging with IVUS in the evaluation of novel antiatherosclerotic therapies.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1016/j.jacc.2010.02.026

Cites

29 of 29 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Carotid-Artery Intima and Media Thickness as a Risk Factor for Myocardial Infarction and Stroke in Older Adults
O'Leary, D. H., Polak, J. F., Kronmal, R. A., Manolio, T. A., Burke, G. L., & Wolfson, S. K. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901073400103 · Cited by 4,685
Coronary Calcium as a Predictor of Coronary Events in Four Racial or Ethnic Groups
Detrano, R., Guerci, A. D., Carr, J. J., Bild, D. E., Burke, G., Folsom, A. R., Liu, K., Shea, S., Szklo, M., Bluemke, D. A., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa072100 · Cited by 2,989
Prediction of Clinical Cardiovascular Events With Carotid Intima-Media Thickness: A Systematic Review and Meta-Analysis
Lorenz, M. W., Markus, H. S., Bots, M. L., Rosvall, M., & Sitzer, M. (2007) · Circulation · doi:10.1161/circulationaha.106.628875 · Cited by 2,977
Effect of Intensive Compared With Moderate Lipid-Lowering Therapy on Progression of Coronary Atherosclerosis
Nissen, S. E., Tuzcu, E. M., Schoenhagen, P., Brown, B. G., Ganz, P., Vogel, R. A., Crowe, T., Howard, G., Cooper, C. J., Brodie, B. R., et al. (2004) · JAMA · doi:10.1001/jama.291.9.1071 · Cited by 2,361
Self-citation
Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B
Brown, G., Albers, J. J., Fisher, L. D., Schaefer, S. M., Lin, J.-T., Kaplan, C., Zhao, X.-Q., Bisson, B. D., Fitzpatrick, V. F., & Dodge, H. T. (1990) · New England Journal of Medicine · doi:10.1056/nejm199011083231901 · Cited by 2,159
Effect of Very High-Intensity Statin Therapy on Regression of Coronary Atherosclerosis: The ASTEROID Trial
Nissen, S. E., Nicholls, S. J., Sipahi, I., Libby, P., Raichlen, J. S., Ballantyne, C. M., Davignon, J., Erbel, R., Fruchart, J. C., Tardif, J.-C., et al. (2006) · JAMA · doi:10.1001/jama.295.13.jpc60002 · Cited by 2,047
Self-citation
Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease
Brown, B. G., Zhao, X.-Q., Chait, A., Fisher, L. D., Cheung, M. C., Morse, J. S., Dowdy, A. A., Marino, E. K., Bolson, E. L., Alaupovic, P., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011090 · Cited by 1,979
Coronary Artery Calcium Score Combined With Framingham Score for Risk Prediction in Asymptomatic Individuals
Greenland, P. (2004) · JAMA · doi:10.1001/jama.291.2.210 · Cited by 1,825
Effect of Recombinant ApoA-I Milano on Coronary Atherosclerosis in Patients With Acute Coronary Syndromes: A Randomized Controlled Trial
Nissen, S. E., Tsunoda, T., Tuzcu, E. M., Schoenhagen, P., Cooper, C. J., Yasin, M., Eaton, G. M., Lauer, M. A., Sheldon, W. S., Grines, C. L., et al. (2003) · JAMA · doi:10.1001/jama.290.17.2292 · Cited by 1,707
Self-citation
Effect of Antihypertensive Agents on Cardiovascular Events in Patients With Coronary Disease and Normal Blood Pressure
Nissen, S. E., Tuzcu, E. M., Libby, P., Thompson, P. D., Ghali, M. G. H., Garza, D., Berman, L., Shi, H. H., Buebendorf, E., Topol, E. J., et al. (2004) · JAMA · doi:10.1001/jama.292.18.2217 · Cited by 1,147
Self-citation

Show all 29 references

Sorted by citations

Items 101–200 of 473

Relationship between fractional flow reserve and residual plaque volume and clinical outcomes after optimal drug-eluting stent implantation: Insight from intravascular ultrasound volumetric analysis
Ito, T., Tani, T., Fujita, H., & Ohte, N. (2014) · International Journal of Cardiology · doi:10.1016/j.ijcard.2014.07.115 · Cited by 43
Effect of treatment with 5‐lipoxygenase inhibitor VIA ‐2291 (atreleuton) on coronary plaque progression: a serial CT angiography study
Matsumoto, S., Ibrahim, R., Grégoire, J. C., L’Allier, P. L., Pressacco, J., Tardif, J., & Budoff, M. J. (2016) · Clinical Cardiology · doi:10.1002/clc.22646 · Cited by 43
HDL Mimetics Infusion and Regression of Atherosclerosis: Is It Still Considered a Valid Therapeutic Option?
Karalis, I. K., & Jukema, J. W. (2018) · Current Cardiology Reports · doi:10.1007/s11886-018-1004-9 · Cited by 43
Relationship between intravascular ultrasound parameters and fractional flow reserve in intermediate coronary artery stenosis of left anterior descending artery: Intravascular ultrasound volumetric analysis
Yang, H., Tahk, S., Lim, H., Yoon, M., Choi, S., Choi, B., Jin, X. J., Hwang, G., Park, J., & Shin, J. (2013) · Catheterization and Cardiovascular Interventions · doi:10.1002/ccd.25088 · Cited by 42
Coronary atheroma regression and adverse cardiac events: A systematic review and meta-regression analysis
Bhindi, R., Guan, M., Zhao, Y., Humphries, K. H., & Mancini, G. B. J. (2019) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2019.03.005 · Cited by 42
Left Main Coronary Atherosclerosis Progression, Constrictive Remodeling, and Clinical Events
Puri, R., Wolski, K., Uno, K., Kataoka, Y., King, K. L., Crowe, T. D., Kapadia, S. R., Tuzcu, E. M., Nissen, S. E., & Nicholls, S. J. (2013) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2012.09.006 · Cited by 41
Self-citation
The Goal of Achieving Atherosclerotic Plaque Regression with Lipid-Lowering Therapy: Insights from IVUS Trials
Daida, H., Dohi, T., Fukushima, Y., Ohmura, H., & Miyauchi, K. (2019) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.48603 · Cited by 41
RVX 208: A novel BET protein inhibitor, role as an inducer of apo A‐I/ HDL and beyond
Ghosh, G. C., Bhadra, R., Ghosh, R. K., Banerjee, K., & Gupta, A. (2017) · Cardiovascular Therapeutics · doi:10.1111/1755-5922.12265 · Cited by 42
Development of a model for prediction of coronary atherosclerotic regression: evaluation of high-density lipoprotein cholesterol level and peripheral blood monocyte count
Tani, S., Matsumoto, M., Anazawa, T., Kawamata, H., Furuya, S., Takahashi, H., Iida, K., Washio, T., Kumabe, N., Kobori, M., et al. (2011) · Heart and Vessels · doi:10.1007/s00380-011-0130-8 · Cited by 40
Coronary β2-adrenoreceptors mediate endothelium-dependent vasoreactivity in humans: novel insights from an in vivo intravascular ultrasound study
Puri, R., Liew, G. Y. H., Nicholls, S. J., Nelson, A. J., Leong, D. P., Carbone, A., Copus, B., Wong, D. T. L., Beltrame, J. F., Worthley, S. G., et al. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehr359 · Cited by 39
Self-citation
Association of calciprotein particles measured by a new method with coronary artery plaque in patients with coronary artery disease: A cross-sectional study
Nakazato, J., Hoshide, S., Wake, M., Miura, Y., Kuro‐o, M., & Kario, K. (2019) · Journal of Cardiology · doi:10.1016/j.jjcc.2019.04.008 · Cited by 39
Relationship Between Serum Inflammatory Marker Levels and the Dynamic Changes in Coronary Plaque Characteristics After Statin Therapy
Kwon, O., Kang, S., Kang, S. H., Lee, P. H., Yun, S., Ahn, J., Park, D., Lee, S., Kim, Y., Lee, C. W., et al. (2017) · Circulation Cardiovascular Imaging · doi:10.1161/circimaging.116.005934 · Cited by 39
Effect of High-Dose Marine Omega-3 Fatty Acids on Atherosclerosis: A Systematic Review and Meta-Analysis of Randomized Clinical Trials
Sekikawa, A. M., Cui, C., Sugiyama, D., Fabio, A., Harris, W. S., & Zhang, X. (2019) · Nutrients · doi:10.3390/nu11112599 · Cited by 38
Mechanistic Insights to Target Atherosclerosis Residual Risk
Alkhalil, M. (2019) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2019.06.004 · Cited by 38
Segmental peri-coronary epicardial adipose tissue volume and coronary plaque characteristics
Hassan, M. S., Said, K., Rizk, H., El-Mogy, F., Donya, M., Houseni, M., & Yacoub, M. H. (2015) · European Heart Journal - Cardiovascular Imaging · doi:10.1093/ehjci/jev298 · Cited by 36
Fundamentals and role of intravascular ultrasound in percutaneous coronary intervention
Xu, J., & Lo, S. T. (2020) · Cardiovascular Diagnosis and Therapy · doi:10.21037/cdt.2020.01.15 · Cited by 36
Progression of ultrasound plaque attenuation and low echogenicity associates with major adverse cardiovascular events
Shishikura, D., Kataoka, Y., Giovanni, G. D., Takata, K., Scherer, D. J., Andrews, J., Psaltis, P. J., Puri, R., Wolski, K., Nissen, S. E., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehaa173 · Cited by 36
Self-citation
Intensive lipid lowering agents and coronary atherosclerosis: Insights from intravascular imaging
Giovanni, G. D., & Nicholls, S. J. (2022) · American Journal of Preventive Cardiology · doi:10.1016/j.ajpc.2022.100366 · Cited by 36
Self-citation
Integrated Biomarker and Imaging Study 3 (IBIS-3) to assess the ability of rosuvastatin to decrease necrotic core in coronary arteries
Oemrawsingh, R. M., García‐García, H. M., van Geuns, R., Lenzen, M. J., Şimşek, C., de Boer, S. P. M., Mieghem, N. M. V., Regar, E. S., de Jaegere, P. P. T., Akkerhuis, K. M., et al. (2016) · EuroIntervention · doi:10.4244/eijv12i6a118 · Cited by 35
Characterization of coronary atherosclerosis by intravascular imaging modalities
Honda, S., Kataoka, Y., Kanaya, T., Noguchi, T., Ogawa, H., & Yasuda, S. (2016) · Cardiovascular Diagnosis and Therapy · doi:10.21037/cdt.2015.12.05 · Cited by 35
High-Risk Morphological and Physiological Coronary Disease Attributes as Outcome Markers After Medical Treatment and Revascularization
Yang, S., Koo, B., Hwang, D., Zhang, J., Hoshino, M., Lee, J. M., Murai, T., Park, J., Shin, E., Doh, J., et al. (2021) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2021.04.004 · Cited by 34
High-Risk Coronary Atheroma
Puri, R., Nicholls, S. J., Ellis, S. G., Tuzcu, E. M., & Kapadia, S. R. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.05.088 · Cited by 34
Self-citation
Intravascular imaging for characterization of coronary atherosclerosis
van Soest, G., Marcu, L., Bouma, B. E., & Regar, E. S. (2017) · Current Opinion in Biomedical Engineering · doi:10.1016/j.cobme.2017.07.001 · Cited by 34
Long-term effect of 2 intensive statin regimens on treatment and incidence of cardiovascular events in familial hypercholesterolemia: The SAFEHEART study
de Isla, L. P., Arroyo-Olivares, R., Muñiz-Grijalvo, O., Díaz-Díaz, J. L., Zambón, D., Fuentes, F. J., Muñoz-Torrero, J. F. S., Mediavilla, J. D., González-Estrada, A., Miramontes‐González, J. P., et al. (2019) · Journal of clinical lipidology · doi:10.1016/j.jacl.2019.10.005 · Cited by 33
Swine Disease Models for Optimal Vascular Engineering
Sturek, M. S., Alloosh, M., & Sellke, F. W. (2020) · Annual Review of Biomedical Engineering · doi:10.1146/annurev-bioeng-082919-053009 · Cited by 33
Plaque Regression Determined by Intravascular Ultrasound Predicts Long-Term Outcomes of Patients with Acute Coronary Syndrome
Dohi, T., Miyauchi, K., Okazaki, S., Yokoyama, T., Yanagisawa, N., Tamura, H., Kojima, T., Yokoyama, K., Kurata, T., & Daida, H. (2011) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.6551 · Cited by 31
Comparison of optical coherence tomography and intravascular ultrasound for evaluation of coronary lipid-rich atherosclerotic plaque progression and regression
Xie, Z., Tian, J., Ma, L., Du, H., Dong, N., Hou, J., He, J., Dai, J., Liu, X., Pan, H., et al. (2015) · European Heart Journal - Cardiovascular Imaging · doi:10.1093/ehjci/jev104 · Cited by 31
Atrial fibrillation, progression of coronary atherosclerosis and myocardial infarction
Bayturan, Ö., Puri, R., Tuzcu, E. M., Shao, M., Wolski, K., Schoenhagen, P., Kapadia, S. R., Nissen, S. E., Sanders, P., & Nicholls, S. J. (2016) · European Journal of Preventive Cardiology · doi:10.1177/2047487316679265 · Cited by 31
Self-citation
ETC-216 for coronary artery disease
Nicholls, S. J., Uno, K., Kataoka, Y., & Nissen, S. E. (2011) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2011.557061 · Cited by 31
Self-citation
PCSK9 inhibition and atherosclerotic cardiovascular disease prevention: does reality match the hype?
Hadjiphilippou, S., & Ray, K. K. (2017) · Heart · doi:10.1136/heartjnl-2016-310844 · Cited by 30
The clinical relevance of the reversal of coronary atherosclerotic plaque
Cesaro, A., Acerbo, V., Indolfi, C., Filardi, P. P., & Calabrò, P. (2024) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2024.08.010 · Cited by 30
Four-year clinical outcomes of the OLIVUS-Ex (impact of Olmesartan on progression of coronary atherosclerosis: Evaluation by intravascular ultrasound) extension trial
Hirohata, A., Yamamoto, K., Miyoshi, T., Hatanaka, K., Hirohata, S., Yamawaki, H., Komatsubara, I., Hirose, E., Kobayashi, Y., Ohkawa, K., et al. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.10.013 · Cited by 30
Regression of coronary atherosclerosis: Current evidence and future perspectives
Koskinas, K. C., Windecker, S., & Räber, L. (2015) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2015.05.004 · Cited by 30
Obesity Is Associated With Progression of Atherosclerosis During Statin Treatment
Sandfort, V., Lai, S., Ahlman, M. A., Mallek, M., Liu, S., Sibley, C. T., Turkbey, E. B., Lima, J. A. C., & Bluemke, D. A. (2016) · Journal of the American Heart Association · doi:10.1161/jaha.116.003621 · Cited by 30
Role of non-statin lipid-lowering therapy in coronary atherosclerosis regression: a meta-analysis and meta-regression
Masson, W. M., Lobo, M., Siniawski, D. A., Molinero, G. B., Masson, G., Huerin, M. S., & Nogueira, J. P. (2020) · Lipids in Health and Disease · doi:10.1186/s12944-020-01297-5 · Cited by 30
Novel Imaging-Based Biomarkers for Identifying Carotid Plaque Vulnerability
Fernández‐Álvarez, V., Linares-Sánchez, M., Suárez, C., López, F., Guntinas‐Lichius, O., Mäkitie, A. A., Bradley, P. J., & Ferlito, A. (2023) · Biomolecules · doi:10.3390/biom13081236 · Cited by 29
Lipid-lowering Therapy and Coronary Plaque Regression
Ueki, Y., Itagaki, T., & Kuwahara, K. (2024) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.rv22024 · Cited by 28
Coronary plaque burden, plaque characterization and their prognostic implications in familial hypercholesterolemia: A computed tomographic angiography study
de Isla, L. P., Rodrigo Alonso, K., de Diego, J. J. G., Muñiz-Grijalvo, O., Díaz-Díaz, J. L., Zambón, D., Miramontes‐González, J. P., Fuentes, F. J., de Andrés, R., Werenitzky, J., et al. (2020) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2020.11.012 · Cited by 28
Impact of Diabetes Mellitus on Vessel Response in the Drug-Eluting Stent Era
Sakata, K., Waseda, K., Kume, T., Otake, H., Nakatani, D., Yock, P. G., Fitzgerald, P. J., & Honda, Y. (2012) · Circulation Cardiovascular Interventions · doi:10.1161/circinterventions.111.962878 · Cited by 28
Proprotein convertase subtilisin/kexin type 9 (PCSK9) and its inhibitors: a review of physiology, biology, and clinical data
Durairaj, A., Sabates, A., Nieves, J., Moraes, B., & Baum, S. (2017) · Current Treatment Options in Cardiovascular Medicine · doi:10.1007/s11936-017-0556-0 · Cited by 27
Rosuvastatin may stabilize atherosclerotic aortic plaque: Transesophageal echocardiographic study in the EPISTEME trial
Ueno, Y., Yamashiro, K., Tanaka, Y., Watanabe, M., Miyamoto, N., Shimada, Y., Kuroki, T., Tanaka, R., Miyauchi, K., Daida, H., et al. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2015.02.021 · Cited by 27
Coronary artery wall shear stress is associated with endothelial dysfunction and expansive arterial remodelling in patients with coronary artery disease
Puri, R., Leong, D. P., Nicholls, S. J., Liew, G. Y. L., Nelson, A. J., Carbone, A., Copus, B., Wong, D. T. L., Beltrame, J. F., Worthley, S. G., et al. (2015) · EuroIntervention · doi:10.4244/eijv10i12a249 · Cited by 27
Self-citation
Rationale and design of a trial to personalize risk assessment in familial coronary artery disease
Marwick, T. H., Whitmore, K., Nicholls, S. J., Stanton, T., Mitchell, G. K., Tonkin, A. M., Blizzard, C. L., Neil, A. L., Jones, C., & Watts, G. F. (2017) · American Heart Journal · doi:10.1016/j.ahj.2017.09.011 · Cited by 27
Self-citation
An alternative method for quantifying coronary artery calcification: the multi-ethnic study of atherosclerosis (MESA)
Liang, C.-P., Budoff, M. J., Kaufman, J. D., Kronmal, R. A., & Brown, E. R. (2012) · BMC Medical Imaging · doi:10.1186/1471-2342-12-14 · Cited by 27
Progression of coronary atherosclerosis in stable patients with ultrasonic features of high-risk plaques
Kataoka, Y., Wolski, K., Balog, C., Uno, K., Puri, R., Tuzcu, E. M., Nissen, S. E., & Nicholls, S. J. (2014) · European Heart Journal - Cardiovascular Imaging · doi:10.1093/ehjci/jeu065 · Cited by 27
Self-citation
Lipid profile associated with coronary plaque regression in patients with acute coronary syndrome: Subanalysis of PRECISE-IVUS trial
Tsujita, K., Yamanaga, K., Komura, N., Sakamoto, K., Sugiyama, S., Sumida, H., Shimomura, H., Yamashita, T., Oka, H., Nakao, K., et al. (2016) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2016.05.025 · Cited by 27
Clinical Significance of Intensive Lipid-Lowering Therapy Using Statins in Patients With Coronary Artery Disease
Miyauchi, K., & Daida, H. (2010) · Circulation Journal · doi:10.1253/circj.cj-10-0565 · Cited by 26
Impact of type 2 diabetes on serial changes in tissue characteristics of coronary plaques: an integrated backscatter intravascular ultrasound analysis
Inaba, S., Okayama, H., Funada, J., Higashi, H., Saito, M., Yoshii, T., Hiasa, G., Sumimoto, T., Takata, Y., Nishimura, K., et al. (2012) · European Heart Journal - Cardiovascular Imaging · doi:10.1093/ehjci/jes033 · Cited by 26
Patterns of coronary plaque progression
Xie, Z., Hou, J., Yu, H., Jia, H., Du, H., Lee, H., Yu, B., Tian, J., & Jang, I. (2016) · Coronary Artery Disease · doi:10.1097/mca.0000000000000420 · Cited by 26
Mechanically Rotating Intravascular Ultrasound (IVUS) Transducer: A Review
Sung, J.-H., & Chang, J. H. (2021) · Sensors · doi:10.3390/s21113907 · Cited by 25
Clinical and Coronary Plaque Predictors of Atherosclerotic Nonresponse to Statin Therapy
Rosendael, S. E. V., van den Hoogen, I. J., Lin, F. Y.-H., Andreini, D., Al-Mallah, M. H., Budoff, M. J., Cademartiri, F., Chinnaiyan, K. M., Choi, J. H., Conte, E., et al. (2022) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2022.10.017 · Cited by 25
Variability and accuracy of coronary CT angiography including use of iterative reconstruction algorithms for plaque burden assessment as compared with intravascular ultrasound—an ex vivo study
Stolzmann, P., Schlett, C. L., Maurovich‐Horvat, P., Maehara, A., Ma, S., Scheffel, H., Engel, L., Károlyi, M., Mintz, G. S., & Hoffmann, U. (2012) · European Radiology · doi:10.1007/s00330-012-2464-8 · Cited by 25
The effects of lipid-lowering therapy on coronary plaque regression: a systematic review and meta-analysis
Li, Y., Deng, S., Liu, B., Yan, Y., Du, J., Li, Y., Jing, X., Liu, Y., Wang, J., Du, J. C., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-87528-w · Cited by 24
Development and Validation of CCTA-based Radiomics Signature for Predicting Coronary Plaques With Rapid Progression
Chen, Q., Xie, G., Tang, C. X., Liu, Y., Xu, P., Gao, X., Lu, M., Fu, Y., Huo, Y., Zheng, S., et al. (2023) · Circulation Cardiovascular Imaging · doi:10.1161/circimaging.123.015340 · Cited by 24
A Functionally Significant Polymorphism in ID3 Is Associated with Human Coronary Pathology
Manichaikul, A. W., Rich, S. S., Perry, H. M., Yeboah, J., Law, M., Davis, M., Parker, M., Ragosta, M., Connelly, J. J., McNamara, C. A., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0090222 · Cited by 24
High-density lipoprotein levels and risk of cardiovascular events
Mureddu, G. F., Brandimarte, F., & Luca, L. D. (2011) · Journal of Cardiovascular Medicine · doi:10.2459/jcm.0b013e32834bb3c8 · Cited by 26
Inflammation, plaque progression and vulnerability: evidence from intravascular ultrasound imaging.
Kataoka, Y., Puri, R., & Nicholls, S. J. (2015) · Europe PMC (PubMed Central) · doi:10.3978/j.issn.2223-3652.2015.05.06 · Cited by 24
Self-citation
Assessment of Plaque Composition by Intravascular Ultrasound and Near-Infrared Spectroscopy
Brugaletta, S., & Sabaté, M. (2014) · Circulation Journal · doi:10.1253/circj.cj-14-0496 · Cited by 23
Smoking in Relation to Coronary Atherosclerotic Plaque Burden, Volume and Composition on Intravascular Ultrasound
Buljubasic, N., Akkerhuis, K. M., de Boer, S. P. M., Cheng, J. M., García‐García, H. M., Lenzen, M. J., Oemrawsingh, R. M., Battes, L. C., Rijndertse, M., Regar, E. S., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0141093 · Cited by 23
Intensive lipid lowering therapy with titrated rosuvastatin yields greater atherosclerotic aortic plaque regression: Serial magnetic resonance imaging observations from RAPID study
Yogo, M., Sasaki, M., Ayaori, M., Kihara, T., Sato, H., Takiguchi, S., Uto‐Kondo, H., Yakushiji, E., Nakaya, K., Komatsu, T., et al. (2013) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2013.10.007 · Cited by 22
Combined heart and kidney transplantation—Is there a protective effect against cardiac allograft vasculopathy using intravascular ultrasound?
Sato, T., Cheng, R., Azarbal, B., Kittleson, M. M., Patel, J. K., Czer, L. S. C., Levine, R., Dimbil, S. J., Olymbios, M., Anzai, T., et al. (2019) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2019.06.012 · Cited by 22
The history of proprotein convertase subtilisin kexin-9 inhibitors and their role in the treatment of cardiovascular disease
Kim, E. J., & Wierzbicki, A. S. (2020) · Therapeutic Advances in Chronic Disease · doi:10.1177/2040622320924569 · Cited by 22
High-risk coronary artery plaque in asymptomatic patients with type 2 diabetes: clinical risk factors and coronary artery calcium score
Heinsen, L. J., Pararajasingam, G., Andersen, T. R., Auscher, S., Sheta, H. M., Precht, H., Lambrechtsen, J., & Egstrup, K. (2021) · Cardiovascular Diabetology · doi:10.1186/s12933-021-01350-2 · Cited by 22
Intravascular imaging assessment of pharmacotherapies targeting atherosclerosis: advantages and limitations in predicting their prognostic implications
Tufaro, V., Serruys, P. W. J. C., Räber, L., Bennett, M. R., Torii, R., Gu, S. Z., Onuma, Y., Mathur, A., Baumbach, A., & Bourantas, C. V. (2022) · Cardiovascular Research · doi:10.1093/cvr/cvac051 · Cited by 22
Common Sequence Variants Associated With Coronary Artery Disease Correlate With the Extent of Coronary Atherosclerosis
Björnsson, E., Gudbjartsson, D. F., Helgadóttir, A., Guðnason, Þ., Guðbjartsson, T., Eyjólfsson, K., Patel, R. S., Ghasemzadeh, N., Þorleifsson, G., Quyyumi, A. A., et al. (2015) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.114.304985 · Cited by 22
Plaque-Stabilizing Effect of Atorvastatin Is Stronger for Plaques Evaluated as More Unstable by Angioscopy and Intravenous Ultrasound
Hirayama, A., Saito, S., Ueda, Y., Takayama, T., Honye, J., Komatsu, S., Yamaguchi, O., Li, Y., Yajima, J., Nanto, S., et al. (2011) · Circulation Journal · doi:10.1253/circj.cj-10-1035 · Cited by 22
Iterative Image Reconstruction Improves the Accuracy of Automated Plaque Burden Assessment in Coronary CT Angiography: A Comparison With Intravascular Ultrasound
Puchner, S. B., Ferencik, M., Maehara, A., Stolzmann, P., Ma, S., Do, S., Kauczor, H., Mintz, G. S., Hoffmann, U., & Schlett, C. L. (2017) · American Journal of Roentgenology · doi:10.2214/ajr.16.17187 · Cited by 22
Oral Calcium Supplements Associate With Serial Coronary Calcification
Bazarbashi, N., Kapadia, S. R., Nicholls, S. J., Carlo, J., Gad, M. M., Kaur, M., Karrthik, A., Sammour, Y. M., Diab, M., Ahuja, K. R., et al. (2020) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2020.06.030 · Cited by 22
Self-citation
Cardiac CT: atherosclerosis to acute coronary syndrome.
Munnur, R. K., Cameron, J. D., Ko, B. S. H., Meredith, I. T., & Wong, D. T. L. (2014) · PubMed Central · doi:10.3978/j.issn.2223-3652.2014.11.03 · Cited by 22
A review of serial coronary computed tomography angiography (CTA) to assess plaque progression and therapeutic effect of anti-atherosclerotic drugs
Taron, J., Lee, S., Aluru, J. S., Hoffmann, U., & Lu, M. T. (2020) · International journal of cardiac imaging · doi:10.1007/s10554-020-01793-w · Cited by 21
The emerging role of plasma lipidomics in cardiovascular drug discovery
Puri, R., Duong, M., Uno, K., Kataoka, Y., & Nicholls, S. J. (2011) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2012.644041 · Cited by 22
Self-citation
Reverse Vessel Remodeling But Not Coronary Plaque Regression Could Predict Future Cardiovascular Events in ACS Patients With Intensive Statin Therapy
Miyauchi, K., Daida, H., Morimoto, T., Hiro, T., Kimura, T., Nakagawa, Y., Yamagishi, M., Ozaki, Y., Kadota, K., Kimura, K., et al. (2012) · Circulation Journal · doi:10.1253/circj.cj-12-0135 · Cited by 21
Coronary atheroma progression rates in men and women following high-intensity statin therapy: A pooled analysis of REVERSAL, ASTEROID and SATURN
Stegman, B., Shao, M., Nicholls, S. J., Elshazly, M. B., Cho, L., King, P. M., Kapadia, S. R., Tuzcu, M., Nissen, S. E., & Puri, R. (2016) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2016.09.059 · Cited by 21
Self-citation
New strategies for the development of lipid-lowering therapies to reduce cardiovascular risk
Graham, I. M., Shear, C. L., de Graeff, P., Boulton, C., Catapano, A. L., Stough, W. G., Carlsson, S. C., Backer, G. D., Emmerich, J., Greenfeder, S. A., et al. (2017) · European Heart Journal - Cardiovascular Pharmacotherapy · doi:10.1093/ehjcvp/pvx031 · Cited by 21
Self-citation
High shear stress on the coronary arterial wall is related to computed tomography-derived high-risk plaque: a three-dimensional computed tomography and color-coded tissue-characterizing intravascular ultrasonography study
Murata, N., Hiro, T., Takayama, T., Migita, S., Morikawa, T., Tamaki, T., Mineki, T., Kojima, K., Akutsu, N., Sudo, M., et al. (2019) · Heart and Vessels · doi:10.1007/s00380-019-01389-y · Cited by 21
Impact of active smoking on the immature platelet fraction and its relationship with the extent of coronary artery disease
Nardin, M., Verdoia, M., Negro, F., Rolla, R., Tonon, F., & Luca, G. D. (2019) · European Journal of Clinical Investigation · doi:10.1111/eci.13181 · Cited by 21
Factors Influencing in-Stent Occlusion after Femoropopliteal Artery Stent Placement with Intravascular Ultrasound Evaluation
Kurata, N., Iida, O., Asai, M., Masuda, M., Okamoto, S., Ishihara, T., Nanto, K., & Mano, T. (2019) · Journal of Vascular and Interventional Radiology · doi:10.1016/j.jvir.2019.08.014 · Cited by 21
Comparison of the Effect of Rosuvastatin 2.5 mg vs 20 mg on Coronary Plaque Determined by Angioscopy and Intravascular Ultrasound in Japanese With Stable Angina Pectoris (from the Aggressive Lipid-Lowering Treatment Approach Using Intensive Rosuvastatin for Vulnerable Coronary Artery Plaque [ALTAIR] Randomized Trial)
Takayama, T., Komatsu, S., Ueda, Y., Fukushima, S., Hiro, T., Hirayama, A., & Saito, S. (2016) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2016.01.013 · Cited by 21
Ezetimibe and Plaque Regression∗
Crea, F., & Niccoli, G. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.05.064 · Cited by 21
Effects of Lipid Lowering Therapies on Vulnerable Plaque Features: An Updated Narrative Review of the Literature
Biccirè, F. G., Gatto, L., Porta, Y. L., Pignatelli, P., Prati, F., & Pastori, D. (2023) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd10060260 · Cited by 20
Guía de Práctica Clínica de la ESC 2013 sobre diagnóstico y tratamiento de la cardiopatía isquémica estable
Montalescot, G., estable, G. D. T. D. L. S. E. D. C. S. D. Y. T. D. L. C. I., Sechtem, U. P., Achenbach, S., Andreotti, F., Arden, C., Budaj, A., Bugiardini, R., Crea, F., Cuisset, T., et al. (2014) · Revista Española de Cardiología · doi:10.1016/j.recesp.2013.11.007 · Cited by 21
Impact of the Low- to High-Density Lipoprotein Cholesterol Ratio on Composition of Angiographically Ambiguous Left Main Coronary Artery Plaque
Kurebayashi, N., Yoshikawa, D., Ishii, H., Sato, B., Ando, H., Okada, T., Hayakawa, S., Okumura, N., Isobe, S., Takeshita, K., et al. (2011) · Circulation Journal · doi:10.1253/circj.cj-11-0019 · Cited by 20
Association of progression or regression of coronary artery atherosclerosis with long-term prognosis
Ndrepepa, G., Iijima, R., Kufner, S., Braun, S., Cassese, S., Byrne, R. A., Sorges, J., Schüpke, S., Hoppmann, P., Fussaro, M., et al. (2016) · American Heart Journal · doi:10.1016/j.ahj.2016.03.016 · Cited by 20
IVUS and OCT: Either or Survivor …
Finn, A. V., Chandrashekhar, Y., & Narula, J. (2011) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2011.08.002 · Cited by 20
Utilizing (serial) coronary computed tomography angiography (CCTA) to predict plaque progression and major adverse cardiac events (MACE): results, merits and challenges
van Driest, F. Y., Bijns, C. M., van der Geest, R. J., Broersen, A., Dijkstra, J., Scholte, A. J. H. A., & Jukema, J. W. (2022) · European Radiology · doi:10.1007/s00330-021-08393-9 · Cited by 19
Association of Lipoprotein(a) With Changes in Coronary Atherosclerosis in Patients Treated With Alirocumab
Koskinas, K. C., Häner, J. D., Ueki, Y., Otsuka, T., Lønborg, J., Shibutani, H., Kakizaki, R., Kaiser, C. A., van Geuns, R., Ondracek, A. S., et al. (2024) · Circulation Cardiovascular Imaging · doi:10.1161/circimaging.124.016683 · Cited by 19
Usefulness of Coronary Atheroma Burden to Predict Cardiovascular Events in Patients Presenting With Acute Coronary Syndromes (from the PROSPECT Study)
Shan, P., Mintz, G. S., McPherson, J., Bruyne, B. D., Farhat, N. Z., Marso, S. P., Serruys, P. W. J. C., Stone, G. W., & Maehara, A. (2015) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2015.08.038 · Cited by 19
Statins, atherosclerosis regression and HDL: Insights from within the plaque
Feig, J. E., Feig, J. L., & Kini, A. S. (2015) · International Journal of Cardiology · doi:10.1016/j.ijcard.2015.04.036 · Cited by 19
Characteristics of Coronary Atherosclerosis Related to Plaque Burden Regression During Treatment With Alirocumab: The ARCHITECT Study
de Isla, L. P., Díaz-Díaz, J. L., Romero-Jiménez, M. J., Muñiz-Grijalvo, O., Mediavilla, J. D., Argüeso, R., de Andrés, R., Fuentes, F. J., Muñoz-Torrero, J. F. S., Rubio, P., et al. (2024) · Circulation Cardiovascular Imaging · doi:10.1161/circimaging.123.016206 · Cited by 18
Usefulness of CHADS2 score for prognostic stratification of patients with coronary artery disease: A systematic review and meta-analysis of cohort studies
Zhou, X., Cao, K., Kou, S., Shencheng, Q. U., Li, H., Yu, Y., Wang, C., Liu, Y., Li, P., & Li, D. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.11.114 · Cited by 18
Meta-Analysis Comparing the Effect of Combined Omega-3 + Statin Therapy Versus Statin Therapy Alone on Coronary Artery Plaques
Fan, H., Zhou, J., & Yuan, Z. (2021) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2021.04.013 · Cited by 18
Effect of Obesity on Coronary Atherosclerosis and Outcomes of Percutaneous Coronary Intervention
Kang, S., Mintz, G. S., Witzenbichler, B., Metzger, D. C., Rinaldi, M. J., Duffy, P. L., Weisz, G., Stuckey, T., Brodie, B. R., Shimizu, T., et al. (2015) · Circulation Cardiovascular Interventions · doi:10.1161/circinterventions.114.001392 · Cited by 18
Advances in dyslipidemia management for prevention of atherosclerosis: PCSK9 monoclonal antibody therapy and beyond
Wong, N. D., Rosenblit, P. D., & Greenfield, R. S. (2017) · Cardiovascular Diagnosis and Therapy · doi:10.21037/cdt.2017.03.02 · Cited by 19
Circulating acute phase proteins in relation to extent and composition of coronary atherosclerosis and cardiovascular outcome: Results from the ATHEROREMO-IVUS study
Battes, L. C., Akkerhuis, K. M., Cheng, J. M., García‐García, H. M., Oemrawsingh, R. M., de Boer, S. P. M., Regar, E. S., van Geuns, R., Serruys, P. W. J. C., Boersma, E. H., et al. (2014) · International Journal of Cardiology · doi:10.1016/j.ijcard.2014.11.001 · Cited by 17
Prospective Validation that Vulnerable Plaque Associated with Major Adverse Outcomes Have Larger Plaque Volume, Less Dense Calcium, and More Non-Calcified Plaque by Quantitative, Three-Dimensional Measurements Using Intravascular Ultrasound with Radiofrequency Backscatter Analysis
Figueroa, J. G. V., Rinehart, S. J., Qian, Z., Joshi, P. H., Sharma, A., Lee, J., Anderson, H., Murrieta, L., Wilmer, C. I., Carlson, H., et al. (2013) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-013-9473-0 · Cited by 17
Visualization of coronary plaque in arterial remodeling using a new 40‐MHz intravascular ultrasound imaging system
Araki, T., Nakamura, M., Utsunomiya, M., & Sugi, K. (2012) · Catheterization and Cardiovascular Interventions · doi:10.1002/ccd.23501 · Cited by 17
Fibrinogen in relation to degree and composition of coronary plaque on intravascular ultrasound in patients undergoing coronary angiography
Buljubasic, N., Akkerhuis, K. M., Cheng, J. M., Oemrawsingh, R. M., García‐García, H. M., de Boer, S. P. M., Regar, E. S., van Geuns, R., Serruys, P. W. J. C., Boersma, E. H., et al. (2016) · Coronary Artery Disease · doi:10.1097/mca.0000000000000442 · Cited by 17
Coronary Plaque Progression and Regression in Asymptomatic African American Chronic Cocaine Users With Obstructive Coronary Stenoses: A Preliminary Study
Sandfort, V., Bluemke, D. A., Vargas, J. D., Brinker, J., Gerstenblith, G., Kickler, T. S., Zheng, G., Li, J., Chen, S., Lai, H. C., et al. (2017) · Journal of Addiction Medicine · doi:10.1097/adm.0000000000000282 · Cited by 17
Efficacy of alirocumab for reducing plaque vulnerability: Study protocol for ALTAIR, a randomized controlled trial in Japanese patients with coronary artery disease receiving rosuvastatin
Otake, H., Sugizaki, Y., Toba, T., Nagano, Y., Tsukiyama, Y., Yanaka, K., Yamamoto, H., Nagasawa, A., Onishi, H., Takeshige, R., et al. (2018) · Journal of Cardiology · doi:10.1016/j.jjcc.2018.11.012 · Cited by 17
High-intensity statin therapy and regression of coronary atherosclerosis in patients with diabetes mellitus
Athyros, V. G., Katsiki, N., Karagiannis, A. I., & Mikhailidis, D. P. (2014) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2014.10.004 · Cited by 17

Authors: Nicholls, S. J., Hsu, A., Wolski, K., Hu, B., Bayturan, O., Lavoie, A., Uno, K., Tuzcu, E. M., & Nissen, S. E.
Affiliations: Cleveland Clinic (US)
Corresponding author: Nicholls, Stephen J.
ORCID: Nicholls, Stephen J.
Wolski, Kathy
Hu, Bo
Lavoie, Andrea
Tuzcu, E. Murat
Nissen, Steven E.
Venue: Journal of the American College of Cardiology
Publisher: Elsevier BV
Published: 2010-05
Volume: 55
Issue: 21
Pages: 2399-2407
ISSN: 0735-1097 (ISSN-L)
DOI: 10.1016/j.jacc.2010.02.026
OpenAlex: W2054455620
Cited by: 475
References: 29
Citations by year: 2026: 20 · 2025: 15 · 2024: 15 · 2023: 25 · 2022: 31 · 2021: 22 · 2020: 24 · 2019: 33 · 2018: 35 · 2017: 32 · 2016: 52 · 2015: 40 · 2014: 41 · 2013: 29 · 2012: 24
FWCI: 30.17
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/legal/tdmrep-license (tdm)
www.elsevier.com/open-access/userlicense/1.0/ (vor, 1172 d)
Locations: Journal of the American College of Cardiology (publishedVersion)
PubMed (publishedVersion)
Institutional Repositories DataBase (IRDB) (submittedVersion)
Funders: Daiichi-Sankyo
Roche
Novo Nordisk
Takeda Pharmaceutical Company
Pfizer
AstraZeneca
Anthera
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Coronary Interventions and Diagnostics
Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Cardiac Imaging and Diagnostics
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cerebrovascular and Carotid Artery Diseases
Keywords: intravascular ultrasound, coronary artery disease, atheroma volume, plaque burden, major adverse cardiovascular events, myocardial infarction, coronary revascularization, plaque progression, cardiovascular risk prediction, smoking, coronary artery stenosis, coronary thrombosis
MeSH terms: Aged, Cardiovascular Diseases, Coronary Artery Disease, Female, Follow-Up Studies, Humans, Male, Middle Aged, Myocardial Infarction, Myocardial Revascularization, Probability, Severity of Illness Index, Cohort Studies, Multivariate Analysis, Confidence Intervals, Logistic Models, Survival Analysis, Treatment Outcome, Ultrasonography, Interventional, Disease Progression, Risk Assessment

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Intravascular Ultrasound-Derived Measures of Coronary Atherosclerotic Plaque Burden and Clinical Outcome

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks